|Research Progression on Biological Mechanism of Post-stroke Depression
|Lin Facai1, Huang Dehong2
|1. Department of Neurology, Guangzhou Hospital of TCM Affiliated to Guangzhou University of TCM, Guangzhou, Guangdong,510130, China 2. Department of Neurology, Guangzhou Hospital of TCM, Guangzhou, Guangdong, 510130, China
| 1 Ried LD, Jia H, Feng H, et al. Selective serotonin reuptake inhibitor treatment and depression are associated with poststrokemortality. Ann Pharmacother 2011; 45: 888-97.
2 Duan PX, Wu SY. Research progression of the integrated Chinese and western medicine on the mechanism of poststroke depression. Chin J Integrated Med on Cardio-/cerebrovascular Dis 2011; 9: 104-6.
3 Xu XG. Clinical analysis of post-cerebral stroke depression: a report of 210 cases. J Tongji Univ 2006; 27: 92-3.
4 Nie YQ, Liu SW, Lv X, et al. Clinical characteristics of patients with post-stroke depression. Chin J Rehabil Theory Pract 2006; 12: 813-4.
5 Grunze A, Meisenzahl E, Grunze H. Neuroimaging of bipolar disorders. Fortschr Neurol Psychiatr 2013; 81: S17-21.
6 Yang LL, Zhang ZJ, Sun DM. Incidences and risk factors of post-stroke depression in patients with acute cerebral stroke. J Clin Neurol 2010; 23: 185-7.
7 Nys GM, van ZandvoortM JE, van derWorpH B, et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke. J Neurol Sci 2006; 247: 149.
8 Narushima K, Kosier JT, Robinson RG. A reappraisal of post stroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 2003; 15: 422-30.
9 Wongwandee M, Tangwongchai S, Phanthumchinda K. Relationship between post-stroke depression and ischemic lesion location. J Med Assoc Thai 2012; 95: 330-6.
10 Ickenstein GW, Riecker A, H?hlig C, et al. Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) instroke and a new NOD step-wise concept. J Neurol 2010; 257: 1492-9.
11 Zhang CQ, Fang XH, Liu HJ, et al. The relationship between post-stroke depression and stroke lesions. Chin J Nerv Ment Dis 2009; 35: 148-51.
12 Guang-Liang D, Michael C, Lian L, et al. Magnetic Resonance Imaging of Stroke in the Rat. Bo Pu Xue Za Zhi 2014; 31: 116-32.
13 Wang YN, Luo YJ. Abnormal emotions in patients with damaged prefrontal cortex. Advances in Psychol Sci 2004; 12: 161-7.
14 Murakami T, Hama S, Yamashita H, et al. Neuroanatomic pathways associated with poststroke affective and apathetic depression. Am J Geriatr Psychiatry 2013; 21: 840-7.
15 Wongwandee M, Tangwongchai S, Phanthumchinda K. Relationship between poststroke depression and ischemic lesion location. J Med Assoc Thai 2012; 95: 330-6.
16 Chen HB, Li F, Wu S, et al. Hippocampus quinolinic acid modulates glutamate and NMDAR/mGluR1 in chronic unpredictable mild stress-induced depression. Sheng Li Xue Bao 2013; 65: 577-85. Chinese.
17 Volumetric MRI analysis of the amygdala and the hippocampus in patients with post-stroke depression. Radiol Pract 2009; 24: 603-6.
18 Pimontel MA, Reinlieb ME, Johnert LC, et al. The external validity of MRI-defined vascular depression. Int J Geriatr Psychiatry 2013; 28: 1189-96.
19 Wang CX, Li B, Guo RY. Imageological analysis and primary explore on pathogenic mechanism of patients with post-stroke depression. Med J Qilu 2011; 26: 336-7.
20 Dong QC, Zhang SP, Ma HR, et al. Clinical analysis of depression disorder after cerebral infarction: a report of 254 cases. Chin J Pract Nerv Dis 2008; 11: 93-5.
21 Li CH, Dun XR, Wu HY, et al. Clinical study of integrated Chinese and western medicine on patients with post-stroke depression. J Chin Med 2014; 29: 106-7.
22 Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry 2010; 55: 341-9.
23 Liebermann D, Ostendorf F, Kopp UA, et al. Subjective cognitive and affective status following thalamic stroke. J Neurol 2013; 260: 386-96.
24 Moller M, Andersen G, Gjedde A. Serotonin 5-HT1A receptor availability and pathological crying after stroke. Acta Neurol Scand 2007; 116: 83-90.
25 Tang WK, Lu JY, Chen YK, et al. Association of frontal subcortical circuits infarcts in poststroke depression: a magnetic resonance imaging study of 591 Chinese patients with ischemic stroke. J Geriatr Psychiatry Neurol 2011; 24: 44-9.
26 Ji YH, Song JG. Relevance between cognitive function, autonomic nervous function and plasma monoamine neurotransmitter levels in patients with post-stroke depression. J Clin Neurol 2007; 20: 426-8.
27 Ma JH, Zhou YS, Li SG, et al. Analysis of relevant factors in patients with post-stroke depression. Chin J General Pract 2009; 7: 945-6.
28 Pascoe MC, Crewther SG, Carey LM, et al. Inflammation and depression: why post-stroke depression may be the norm and not the exception. Int J Stroke 2011; 6: 128-35.
29 Huang K, Chen M. Relevance analysis of serum highsensitivity C-reactive protein level and post-stroke depression in patients with acute cerebral stroke. J Pract Med 2009; 25: 572-3.
30 Spalletta G, Bossu P, Ciaramella A, et al. The etiology of post-stroke depression：a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry 2006; 11: 984-91.
31 Su JA, Chou SY, Tsai CS, et al. Cytokine changes in the pathophysiology of post-stroke depression. Gen Hosp Psychiatry 2012; 34: 35-9.
32 Lu M, Zhao HD, Tang B. Relevance analysis of hyperhomocysteinemina and recurrence of acute ischemic cerebral stroke. J Brain Nerv Dis 2012; 20: 217-20.
33 Shi N, Xue YD, Gao XR. Study on relationship between location of cerebral infarction and plasma homocysteine level with post-stroke depression. J Clin Experimental Med 2012; 11: 1851-2.
34 Xu WJ, Shi XD, Zhang WJ, et al. Study on the plasma homocysteine level in patients with post-stroke depression. J Apoplexy Nerv Dis 2011; 28: 840-1.
35 Nanri A, Mizoue T, Matsushita Y, et al. Serum folate and homocysteine and depressive symptoms among Japanese men and women. Eur J Clin Nutr 2010; 64: 289-96.
36 Wang HS, Li MX, Hong CX. Study on thyroid function in patients with depression after acute cerebral infarction. Chin J Integrated Med on Cardio-/cerebrovascular Dis 2005; 3: 499-500.
37 Zhang ZH, Wu LN, Song JG, et al. Correlations between cognitive impairment and brain?derived neurotrophic factor expression in thehippocampus of poststroke depression rats. Mol Med Rep 2012; 6: 889-93.
38 Ma YX. Research progression of neurobiological mechanism of depression. J Hebei Med Univ 2006; 27: 594-6.
39 Li DF, Li GL, Xue CS, et al. Clinical study on the changes of thyroid function in patients with acute cerebral stroke. Chin J Geriatric Cardiov Cerebrov Dis 2013; 39: 119-22.
40 Wu YG, Chu ZH. Research progression of neurobiological mechanism of depression. Chin J Nerv Ment Dis 2013; 39: 119-22.
41 Kronenberg G, Balkaya M, Prinz V, et al. Exofocal dopaminergic degeneration as antidepressant target in mouse model of post-stroke depression. Biol Psychiatry 2012; 72: 273-81.
42 Kang HJ, Stewart R, Kim JM, et al. Comparative validity of depression assessment scales for screening poststroke depression. J Affect Disord 2013; 147: 186-91.
43 Kauhanen ML, Korpelainen JT, Hiltunen P, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 1999; 30: 1875-80.
44 Sun FZ, Su JF, Yuan YP, et al. Analysis on relevant factors in patients with post-stroke depression. Chin J Integrated Med on Cardio-/cerebrov Dis 2008; 6: 122-3.
45 Zhao X. Clinical report of post-cerebral stroke depression: a report of 68 cases. Clin Report 2010; 6: 134-5.
||TAN Mi-duo. Research Progress of Translational Medicine in Breast Cancer[J]. Journal of International Translational Medicine, 2017, 5(2): 86-91.
||SHEN Bo, LU Jian-wei, ZHANG Yan, WU Yuan, YUAN Yuan, FENG Ji-feng. Research Progress of MicroRNAs in Gastric Cancer[J]. Journal of International Translational Medicine, 2017, 5(2): 71-79.
||Lukas Gietz, Benjamin Mayer. A Resampling Approach for Sample Size Estimation in Animal Experiments[J]. Journal of International Translational Medicine, 2017, 5(2): 53-62.
||QIAN Ting, HUANG Xin-en. Comparison of the Efficacy and Safety of Pemetrexed-Based Versus Paclitaxel-Based Chemotherapy as Third-Line Treatment for Patients with Advanced Breast Cancer[J]. Journal of International Translational Medicine, 2017, 5(2): 63-66.
||MAO Xiao-dong, ZHE Yi, CHEN Ya-jun, LIU Kang-sheng. Detection of Serum Anti-Müllerian Hormone Level for Women of Reproductive Age: A Cross-Sectional Study[J]. Journal of International Translational Medicine, 2017, 5(2): 67-70.
||LIU Yong-jun, ZHOU Yan. Advances of PD-1/PD-L1 Inhibitors in Tumor Immunotherapy[J]. Journal of International Translational Medicine, 2017, 5(2): 80-85.